Home - RESEARCH & DEVELOPMENT - Clinical Development
Clinical Development
  • Clinical Development
  • Translational Medicine Research Center
  • Pipeline
  • CLINICAL DEVELOPMENT-THE BOTTLENECK OF INNOVATIVE DRUG DEVELOPMENT IN CHINA
    CLINICAL DEVELOPMENT IS EXTREMELY DIFFICULT AND DEMANDING Clinical development is the only method to test a drug's safety and effectiveness in humans, and directly determines the success or failure of an innovative drug.
    CHALLENGES FOR CLINICAL DEVELOPMENT IN CHINA

    Compared to western countries, China is a late starter in clinical development, and has limited experience in designing clinical studies. Also, the number of clinical studies (especially PhI) are relatively low and the quality varies greatly.

    INDEPENDENTLY DEVELOPED, CLINICALLY DRIVEN

    —— BUILD A LEADING MODEL FOR INNOVATIVE DRUG DEVELOPMENT

    Translational Medicine Research Center

    Build a first-class domestic platform for research, collaboration, and talent development

    Boost translational medicine, enrich R&D pipeline, and enhance clinical studies

    • Global Strategic Product Acquisitions and Co-Developments

      With a focus on China's high-incidence cancers and the needs of Chinese patients, in-license attractive assets globally or custom design and develop through preclinical CROs

    • World-Class
      “Clinical Development Engine”
      Global standards, China focused

      Leverage the clinical team's industry-leading capabilities to accelerate clinical development & drug registration, while adhering to international standards and quality

    • Commercialize Products in China and Globally

      Build internal commercial infrastructure in China

      Co-develop and co-market outside China

    CSTONE HAS THE WEAPON TO BREAK THE BOTTLENECK OF CLINICAL DEVELOPMENT
    A HIGH-QUALITY, HIGH-EFFICIENCY, AND LOW-COST MODEL FOR INNOVATIVE DRUG DEVELOPMENT
    High-Quality, Low-Cost

    To ensure quality, CStone keeps the most critical clinical development functions in-house; while collaborating with the best CROs to lower operating costs and conduct multiple clinical trials simultaneously

    High-Efficiency

    Leverage an innovative model to shorten the timeline for clinical development